{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T15:12:50Z","timestamp":1785597170261,"version":"3.56.0"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["483225\/2012-6"],"award-info":[{"award-number":["483225\/2012-6"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2011\/12656-2"],"award-info":[{"award-number":["2011\/12656-2"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","fsigenetics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Forensic Science International: Genetics"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.fsigen.2021.102478","type":"journal-article","created":{"date-parts":[[2021,2,5]],"date-time":"2021-02-05T20:47:15Z","timestamp":1612558035000},"page":"102478","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Association of variants in MYH7, MYBPC3 and TNNT2 with sudden cardiac death-related risk factors in Brazilian patients with hypertrophic cardiomyopathy"],"prefix":"10.1016","volume":"52","author":[{"given":"Augusto Akira","family":"Mori","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lara Reinel de","family":"Castro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raul Hernandes","family":"Bortolin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gisele Medeiros","family":"Bastos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor Fernandes de","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glaucio Monteiro","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thiago Dominguez Crespo","family":"Hirata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina Moreno","family":"Fajardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcelo Ferraz","family":"Sampaio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dalmo Antonio Ribeiro","family":"Moreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Carlos","family":"Pach\u00f3n-Mateos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edileide de Barros","family":"Correia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda Guerra de Moraes Rego","family":"Sousa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Bri\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angel","family":"Carracedo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosario Dominguez Crespo","family":"Hirata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario Hiroyuki","family":"Hirata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.fsigen.2021.102478_bib1","first-page":"640","article-title":"Cardiomyopathy: an overview","volume":"96","author":"Brieler","year":"2017","journal-title":"Am. Fam. Physician"},{"issue":"7","key":"10.1016\/j.fsigen.2021.102478_bib2","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1161\/CIRCRESAHA.117.311059","article-title":"Hypertrophic cardiomyopathy: genetics, pathogenesis, clinical manifestations, diagnosis, and therapy","volume":"121","author":"Marian","year":"2017","journal-title":"Circ. Res."},{"issue":"6","key":"10.1016\/j.fsigen.2021.102478_bib3","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.joa.2017.07.005","article-title":"Syncope and the risk of sudden cardiac death: evaluation, management, and prevention","volume":"33","author":"Koene","year":"2017","journal-title":"J. Arrhythm."},{"issue":"11","key":"10.1016\/j.fsigen.2021.102478_bib4","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1177\/2047487317702519","article-title":"Risk factors for sudden cardiac death in childhood hypertrophic cardiomyopathy: a systematic review and meta-analysis","volume":"24","author":"Norrish","year":"2017","journal-title":"Eur. J. Prev. Cardiol."},{"issue":"5","key":"10.1016\/j.fsigen.2021.102478_bib5","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCGENETICS.117.001768","article-title":"A comparison of whole genome sequencing to multigene panel testing in hypertrophic cardiomyopathy patients","volume":"10","author":"Cirino","year":"2017","journal-title":"Circ. Cardiovasc. Genet."},{"issue":"4","key":"10.1016\/j.fsigen.2021.102478_bib6","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.jacc.2018.04.078","article-title":"Whole genome sequencing improves outcomes of genetic testing in patients with hypertrophic cardiomyopathy","volume":"72","author":"Bagnall","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.fsigen.2021.102478_bib7","doi-asserted-by":"crossref","first-page":"16609","DOI":"10.1038\/srep16609","article-title":"Investigation of pathogenic genes in chinese sporadic hypertrophic cardiomyopathy patients by whole exome sequencing","volume":"5","author":"Xu","year":"2015","journal-title":"Sci. Rep."},{"issue":"7","key":"10.1016\/j.fsigen.2021.102478_bib8","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1038\/s41436-018-0375-z","article-title":"Analysis of 51 proposed hypertrophic cardiomyopathy genes from genome sequencing data in sarcomere negative cases has negligible diagnostic yield","volume":"21","author":"Thomson","year":"2019","journal-title":"Genet. Med."},{"issue":"1","key":"10.1016\/j.fsigen.2021.102478_bib9","doi-asserted-by":"crossref","first-page":"10846","DOI":"10.1038\/s41598-018-29263-3","article-title":"Coverage and diagnostic yield of whole exome sequencing for the evaluation of cases with dilated and hypertrophic cardiomyopathy","volume":"8","author":"Mak","year":"2018","journal-title":"Sci. Rep."},{"issue":"8","key":"10.1016\/j.fsigen.2021.102478_bib10","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0182946","article-title":"Whole gene sequencing identifies deep-intronic variants with potential functional impact in patients with hypertrophic cardiomyopathy","volume":"12","author":"Mendes de Almeida","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.fsigen.2021.102478_bib11","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1146\/annurev-genom-083118-015306","article-title":"Advances in the genetic basis and pathogenesis of sarcomere cardiomyopathies","volume":"20","author":"Yotti","year":"2019","journal-title":"Annu Rev. Genom. Hum. Genet."},{"issue":"1","key":"10.1016\/j.fsigen.2021.102478_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.gene.2016.01.006","article-title":"TNNT1, TNNT2 and TNNT3: isoform genes, regulation, and structure\u2013function relationships","volume":"582","author":"Wei","year":"2016","journal-title":"Gene"},{"issue":"4","key":"10.1016\/j.fsigen.2021.102478_bib13","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.ahj.2013.07.029","article-title":"Screening of MYH7, MYBPC3 and TNNT2 genes in Brazilian patients with hypertrophic cardiomyopathy","volume":"166","author":"Marsiglia","year":"2013","journal-title":"Am. Heart J."},{"issue":"4","key":"10.1016\/j.fsigen.2021.102478_bib14","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.jmoldx.2015.02.003","article-title":"A variant detection pipeline for inherited cardiomyopathy-associated genes using next-generation sequencing","volume":"17","author":"Oliveira","year":"2015","journal-title":"J. Mol. Diagn."},{"issue":"3","key":"10.1016\/j.fsigen.2021.102478_bib15","first-page":"257","article-title":"Prevalence and phenotypic expression of mutations in the MYH7, MYBPC3 and TNNT2 genes in families with hypertrophic cardiomyopathy in the South of Brazil: a cross-sectional study","volume":"107","author":"Mattos","year":"2016","journal-title":"Arq. Bras. Cardiol."},{"issue":"4","key":"10.1016\/j.fsigen.2021.102478_bib16","first-page":"354","article-title":"Myosin-binding protein C compound heterozygous variant effect on the phenotypic expression of hypertrophic cardiomyopathy","volume":"108","author":"Rafael","year":"2017","journal-title":"Arq. Bras. Cardiol."},{"issue":"25","key":"10.1016\/j.fsigen.2021.102478_bib17","doi-asserted-by":"crossref","first-page":"e212","DOI":"10.1016\/j.jacc.2011.06.011","article-title":"2011 ACCF\/AHA Guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on practice guidelines","volume":"58","author":"Gersh","year":"2011","journal-title":"J. Am. Coll. Cardiol."},{"issue":"39","key":"10.1016\/j.fsigen.2021.102478_bib18","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1093\/eurheartj\/ehu284","article-title":"2014 ESC guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task force for the diagnosis and management of hypertrophic cardiomyopathy of the European Society of Cardiology (ESC)","volume":"35","author":"Elliott","year":"2014","journal-title":"Eur. Heart J."},{"issue":"7","key":"10.1016\/j.fsigen.2021.102478_bib19","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1056\/NEJMra1710575","article-title":"Clinical course and management of hypertrophic cardiomyopathy","volume":"379","author":"Maron","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"9","key":"10.1016\/j.fsigen.2021.102478_bib20","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1101\/gr.107524.110","article-title":"The genome analysis toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data","volume":"20","author":"McKenna","year":"2010","journal-title":"Genome Res."},{"issue":"1110","key":"10.1016\/j.fsigen.2021.102478_bib21","first-page":"11.10.1","article-title":"From FastQ data to high\u2010confidence variant calls: the genome analysis toolkit best practices pipeline","volume":"43","author":"Auwera","year":"2013","journal-title":"Curr. Protoc. Bioinforma."},{"issue":"16","key":"10.1016\/j.fsigen.2021.102478_bib22","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkq603","article-title":"ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data","volume":"38","author":"Wang","year":"2010","journal-title":"Nucleic Acids Res."},{"issue":"5","key":"10.1016\/j.fsigen.2021.102478_bib23","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med."},{"issue":"3","key":"10.1016\/j.fsigen.2021.102478_bib24","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/gim.2017.218","article-title":"Adaptation and validation of the ACMG\/AMP variant classification framework for MYH7-associated inherited cardiomyopathies: recommendations by ClinGen\u2019s Inherited Cardiomyopathy Expert Panel","volume":"20","author":"Kelly","year":"2018","journal-title":"Genet Med"},{"key":"10.1016\/j.fsigen.2021.102478_bib25","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/bs.apcsb.2019.11.013","article-title":"Computational approaches for identifying potential inhibitors on targeting protein interactions in drug discovery","volume":"121","author":"Kanakaveti","year":"2020","journal-title":"Adv. Protein Chem. Struct. Biol."},{"issue":"7","key":"10.1016\/j.fsigen.2021.102478_bib26","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1002\/humu.23220","article-title":"Exomic variants of an elderly cohort of Brazilians in the ABraOM database","volume":"38","author":"Naslavsky","year":"2017","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.fsigen.2021.102478_bib27","article-title":"Phenotypes of hypertrophic cardiomyopathy: genetics, clinics, and modular imaging","author":"Muresan","year":"2020","journal-title":"Heart Fail Rev."},{"issue":"1","key":"10.1016\/j.fsigen.2021.102478_bib28","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s00392-017-1155-5","article-title":"Clinical outcomes associated with sarcomere mutations in hypertrophic cardiomyopathy: a meta-analysis on 7675 individuals","volume":"107","author":"Sedaghat-Hamedani","year":"2018","journal-title":"Clin. Res. Cardiol."},{"issue":"11","key":"10.1016\/j.fsigen.2021.102478_bib29","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1093\/eurjhf\/hfr074","article-title":"Novel correlations between the genotype and the phenotype of hypertrophic and dilated cardiomyopathy: results from the German Competence Network Heart Failure","volume":"13","author":"Waldm\u00fcller","year":"2011","journal-title":"Eur. J. Heart Fail"},{"issue":"1\u20133","key":"10.1016\/j.fsigen.2021.102478_bib30","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.forsciint.2012.01.018","article-title":"Sarcomeric gene mutations in sudden infant death syndrome (SIDS)","volume":"219","author":"Brion","year":"2012","journal-title":"Forensic Sci. Int."},{"issue":"14","key":"10.1016\/j.fsigen.2021.102478_bib31","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1161\/CIRCULATIONAHA.117.033200","article-title":"Genotype and lifetime burden of disease in hypertrophic cardiomyopathy: insights from the Sarcomeric Human Cardiomyopathy Registry (SHaRe)","volume":"138","author":"Ho","year":"2018","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.fsigen.2021.102478_bib32","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s12265-012-9425-0","article-title":"Early results of sarcomeric gene screening from the Egyptian National BA-HCM Program","volume":"6","author":"Kassem","year":"2013","journal-title":"J. Cardiovasc. Transl. Res."},{"issue":"6","key":"10.1016\/j.fsigen.2021.102478_bib33","doi-asserted-by":"crossref","first-page":"3969","DOI":"10.1007\/s11033-012-2474-2","article-title":"Multiple gene mutations, not the type of mutation, are the modifier of left ventricle hypertrophy in patients with hypertrophic cardiomyopathy","volume":"40","author":"Zou","year":"2013","journal-title":"Mol. Biol. Rep."},{"issue":"3","key":"10.1016\/j.fsigen.2021.102478_bib34","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s12265-014-9542-z","article-title":"Distinguishing hypertrophic cardiomyopathy-associated mutations from background genetic noise","volume":"7","author":"Kapplinger","year":"2014","journal-title":"J. Cardiovasc. Transl. Res."},{"issue":"1","key":"10.1016\/j.fsigen.2021.102478_bib35","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s13073-017-0403-7","article-title":"Pathogenic variant burden in the ExAC database: an empirical approach to evaluating population data for clinical variant interpretation","volume":"9","author":"Kobayashi","year":"2017","journal-title":"Genome Med."},{"issue":"6","key":"10.1016\/j.fsigen.2021.102478_bib36","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.3390\/jcm9061636","article-title":"Risk stratification in hypertrophic cardiomyopathy. Insights from genetic analysis and cardiopulmonary exercise testing","volume":"9","author":"Magr\u00ec","year":"2020","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.fsigen.2021.102478_bib37","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.ijcard.2018.12.012","article-title":"Genetic characterization and genotype-phenotype associations in a large cohort of patients with hypertrophic cardiomyopathy \u2013 an ancillary study of the Portuguese registry of hypertrophic cardiomyopathy","volume":"278","author":"Lopes","year":"2019","journal-title":"Int J. Cardiol."},{"issue":"11","key":"10.1016\/j.fsigen.2021.102478_bib38","doi-asserted-by":"crossref","first-page":"2894","DOI":"10.1002\/jcp.22636","article-title":"Unexpectedly low mutation rates in beta-myosin heavy chain and cardiac myosin binding protein genes in italian patients with hypertrophic cardiomyopathy","volume":"226","author":"Roncarati","year":"2011","journal-title":"J. Cell Physiol."},{"key":"10.1016\/j.fsigen.2021.102478_bib39","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1471-2350-13-17","article-title":"High resolution melting: improvements in the genetic diagnosis of hypertrophic cardiomyopathy in a Portuguese cohort","volume":"13","author":"Santos","year":"2012","journal-title":"BMC Med. Genet."},{"issue":"14","key":"10.1016\/j.fsigen.2021.102478_bib40","doi-asserted-by":"crossref","first-page":"6828","DOI":"10.1073\/pnas.1816480116","article-title":"Revealing the mechanism of how cardiac myosin-binding protein C N-terminal fragments sensitize thin filaments for myosin binding","volume":"116","author":"Inchingolo","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"9","key":"10.1016\/j.fsigen.2021.102478_bib41","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.118.005191","article-title":"Incident atrial fibrillation is associated with MYH7 sarcomeric gene variation in hypertrophic cardiomyopathy: results from the International Sarcomeric Human Cardiomyopathy Registry","volume":"11","author":"Lee","year":"2018","journal-title":"Circ. Heart Fail."},{"issue":"1","key":"10.1016\/j.fsigen.2021.102478_bib42","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1038\/s41598-018-20114-9","article-title":"Genetic basis of cardiomyopathy and the genotypes involved in prognosis and left ventricular reverse remodeling","volume":"8","author":"Tobita","year":"2018","journal-title":"Sci. Rep."},{"issue":"9","key":"10.1016\/j.fsigen.2021.102478_bib43","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1038\/ejhg.2012.283","article-title":"New population-based exome data are questioning the pathogenicity of previously cardiomyopathy-associated genetic variants","volume":"21","author":"Andreasen","year":"2013","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.fsigen.2021.102478_bib44","doi-asserted-by":"crossref","first-page":"429","DOI":"10.3389\/fphys.2016.00429","article-title":"Cardiac troponin and tropomyosin: structural and cellular perspectives to unveil the hypertrophic cardiomyopathy phenotype.","volume":"7","author":"Marques","year":"2016","journal-title":"Front. Physiol."},{"issue":"8","key":"10.1016\/j.fsigen.2021.102478_bib45","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.015316","article-title":"Increased myocardial oxygen consumption precedes contractile dysfunction in hypertrophic cardiomyopathy caused by pathogenic TNNT2 gene variants","volume":"9","author":"Parbhudayal","year":"2020","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.fsigen.2021.102478_bib46","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.yjmcc.2020.04.005","article-title":"Meta-analysis of cardiomyopathy-associated variants in troponin genes identifies loci and intragenic hot spots that are associated with worse clinical outcomes","volume":"142","author":"Tadros","year":"2020","journal-title":"J. Mol. Cell Cardiol."},{"key":"10.1016\/j.fsigen.2021.102478_bib47","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/1471-2261-14-36","article-title":"Clinical predictors of a positive genetic test in hypertrophic cardiomyopathy in the Brazilian population","volume":"14","author":"Marsiglia","year":"2014","journal-title":"BMC Cardiovasc. Disord."},{"issue":"4","key":"10.1016\/j.fsigen.2021.102478_bib48","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCGENETICS.116.001660","article-title":"Clinical characteristics and long-term outcome of hypertrophic cardiomyopathy in individuals with a MYBPC3 (Myosin-Binding Protein C) founder mutation","volume":"10","author":"van Velzen","year":"2017","journal-title":"Circ. Cardiovasc. Genet."}],"container-title":["Forensic Science International: Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S187249732100017X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S187249732100017X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T11:03:53Z","timestamp":1761735833000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S187249732100017X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":48,"alternative-id":["S187249732100017X"],"URL":"https:\/\/doi.org\/10.1016\/j.fsigen.2021.102478","relation":{},"ISSN":["1872-4973"],"issn-type":[{"value":"1872-4973","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association of variants in MYH7, MYBPC3 and TNNT2 with sudden cardiac death-related risk factors in Brazilian patients with hypertrophic cardiomyopathy","name":"articletitle","label":"Article Title"},{"value":"Forensic Science International: Genetics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fsigen.2021.102478","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102478"}}